Skip to main content
Erschienen in: Diabetologia 5/2017

11.01.2017 | Article

Glucose and fatty acids synergistically and reversibly promote beta cell proliferation in rats

verfasst von: Valentine S. Moullé, Kevin Vivot, Caroline Tremblay, Bader Zarrouki, Julien Ghislain, Vincent Poitout

Erschienen in: Diabetologia | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The mechanisms underlying pancreatic islet mass expansion have attracted considerable interest as potential therapeutic targets to prevent or delay the onset of type 2 diabetes. While several factors promoting beta cell proliferation have been identified, in the context of nutrient excess the roles of glucose or NEFA in relation to insulin resistance remain unclear. Here we tested the hypothesis that glucose and NEFA synergistically and reversibly promote beta cell proliferation in the context of nutrient-induced insulin resistance.

Methods

Using 72 h infusions of glucose (GLU) or the oleate-enriched lipid emulsion ClinOleic (CLI), singly or in combination, we assessed beta cell proliferation, islet mass and insulin sensitivity in male Lewis rats. The effects of nutrients and endogenous circulating factors were examined in isolated and transplanted islets. Reversibility was studied 3 and 6 days after the end of the infusion.

Results

GLU infusions modestly stimulated beta cell proliferation, CLI alone had no effect and GLU+CLI infusions markedly stimulated beta cell proliferation. Insulin sensitivity was equally decreased in GLU and GLU+CLI infusions. GLU+CLI infusions also stimulated beta cell proliferation in islets transplanted under the kidney capsule, albeit to a lesser extent compared with endogenous islets. Ex vivo, the combination of glucose and NEFA enhanced beta cell proliferation in rat and human islets independently from secreted insulin, and serum from GLU+CLI-infused rats potentiated the effect of glucose. Glucose tolerance, beta cell proliferation and islet mass were all restored to normal levels 6 days after termination of the infusion.

Conclusions/interpretation

Glucose and NEFA synergistically and reversibly promote beta cell proliferation in part via direct action on the beta cell and independently from secreted insulin.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Kahn SE, Cooper ME, Del Prato S (2014) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383:1068–1083CrossRefPubMed Kahn SE, Cooper ME, Del Prato S (2014) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383:1068–1083CrossRefPubMed
3.
Zurück zum Zitat Wang P, Alvarez-Perez JC, Felsenfeld DP et al (2015) A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat Med 21:383–388CrossRefPubMedPubMedCentral Wang P, Alvarez-Perez JC, Felsenfeld DP et al (2015) A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat Med 21:383–388CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Kulkarni RN, Mizrachi EB, Ocana AG, Stewart AF (2012) Human β-cell proliferation and intracellular signaling: driving in the dark without a road map. Diabetes 61:2205–2213CrossRefPubMedPubMedCentral Kulkarni RN, Mizrachi EB, Ocana AG, Stewart AF (2012) Human β-cell proliferation and intracellular signaling: driving in the dark without a road map. Diabetes 61:2205–2213CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Bernal-Mizrachi E, Kulkarni RN, Scott DK, Mauvais-Jarvis F, Stewart AF, Garcia-Ocana A (2014) Human β-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map. Diabetes 63:819–831CrossRefPubMedPubMedCentral Bernal-Mizrachi E, Kulkarni RN, Scott DK, Mauvais-Jarvis F, Stewart AF, Garcia-Ocana A (2014) Human β-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map. Diabetes 63:819–831CrossRefPubMedPubMedCentral
8.
9.
Zurück zum Zitat Steil GM, Trivedi N, Jonas JC et al (2001) Adaptation of β-cell mass to substrate oversupply: enhanced function with normal gene expression. Am J Phys Endocrinol Metab 280:E788–E796 Steil GM, Trivedi N, Jonas JC et al (2001) Adaptation of β-cell mass to substrate oversupply: enhanced function with normal gene expression. Am J Phys Endocrinol Metab 280:E788–E796
10.
Zurück zum Zitat Pascoe J, Hollern D, Stamateris R et al (2012) Free fatty acids block glucose-induced β-cell proliferation in mice by inducing cell cycle inhibitors p16 and p18. Diabetes 61:632–641CrossRefPubMedPubMedCentral Pascoe J, Hollern D, Stamateris R et al (2012) Free fatty acids block glucose-induced β-cell proliferation in mice by inducing cell cycle inhibitors p16 and p18. Diabetes 61:632–641CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Bernard C, Thibault C, Berthault MF et al (1998) Pancreatic β-cell regeneration after 48-h glucose infusion in mildly diabetic rats is not correlated with functional improvement. Diabetes 47:1058–1065CrossRefPubMed Bernard C, Thibault C, Berthault MF et al (1998) Pancreatic β-cell regeneration after 48-h glucose infusion in mildly diabetic rats is not correlated with functional improvement. Diabetes 47:1058–1065CrossRefPubMed
12.
Zurück zum Zitat Paris M, Bernard-Kargar C, Berthault MF, Bouwens L, Ktorza A (2003) Specific and combined effects of insulin and glucose on functional pancreatic β-cell mass in vivo in adult rats. Endocrinology 144:2717–2727CrossRefPubMed Paris M, Bernard-Kargar C, Berthault MF, Bouwens L, Ktorza A (2003) Specific and combined effects of insulin and glucose on functional pancreatic β-cell mass in vivo in adult rats. Endocrinology 144:2717–2727CrossRefPubMed
13.
Zurück zum Zitat Zarrouki B, Benterki I, Fontes G et al (2014) Epidermal growth factor receptor signaling promotes pancreatic β-cell proliferation in response to nutrient excess in rats through mTOR and FOXM1. Diabetes 63:982–993CrossRefPubMedPubMedCentral Zarrouki B, Benterki I, Fontes G et al (2014) Epidermal growth factor receptor signaling promotes pancreatic β-cell proliferation in response to nutrient excess in rats through mTOR and FOXM1. Diabetes 63:982–993CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Fontes G, Zarrouki B, Hagman DK et al (2010) Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass. Diabetologia 53:2369–2379CrossRefPubMedPubMedCentral Fontes G, Zarrouki B, Hagman DK et al (2010) Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass. Diabetologia 53:2369–2379CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Hagman DK, Latour MG, Chakrabarti SK et al (2008) Cyclical and alternating infusions of glucose and intralipid in rats inhibit insulin gene expression and Pdx-1 binding in islets. Diabetes 57:424–431CrossRefPubMed Hagman DK, Latour MG, Chakrabarti SK et al (2008) Cyclical and alternating infusions of glucose and intralipid in rats inhibit insulin gene expression and Pdx-1 binding in islets. Diabetes 57:424–431CrossRefPubMed
16.
Zurück zum Zitat Fergusson G, Ethier M, Guevremont M et al (2014) Defective insulin secretory response to intravenous glucose in C57Bl/6J compared to C57Bl/6N mice. Mol Metab 3:848–854CrossRefPubMedPubMedCentral Fergusson G, Ethier M, Guevremont M et al (2014) Defective insulin secretory response to intravenous glucose in C57Bl/6J compared to C57Bl/6N mice. Mol Metab 3:848–854CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Jacqueminet S, Briaud I, Rouault C, Reach G, Poitout V (2000) Inhibition of insulin gene expression by long-term exposure of pancreatic β cells to palmitate is dependent on the presence of a stimulatory glucose concentration. Metab Clin Exp 49:532–536CrossRefPubMed Jacqueminet S, Briaud I, Rouault C, Reach G, Poitout V (2000) Inhibition of insulin gene expression by long-term exposure of pancreatic β cells to palmitate is dependent on the presence of a stimulatory glucose concentration. Metab Clin Exp 49:532–536CrossRefPubMed
18.
Zurück zum Zitat Escriva F, Agote M, Rubio E et al (1997) In vivo insulin-dependent glucose uptake of specific tissues is decreased during aging of mature Wistar rats. Endocrinology 138:49–54 Escriva F, Agote M, Rubio E et al (1997) In vivo insulin-dependent glucose uptake of specific tissues is decreased during aging of mature Wistar rats. Endocrinology 138:49–54
19.
Zurück zum Zitat Defronzo RA (1979) Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 28:1095–1101CrossRefPubMed Defronzo RA (1979) Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 28:1095–1101CrossRefPubMed
20.
Zurück zum Zitat Bonner-Weir S, Deery D, Leahy JL, Weir GC (1989) Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 38:49–53CrossRefPubMed Bonner-Weir S, Deery D, Leahy JL, Weir GC (1989) Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 38:49–53CrossRefPubMed
22.
Zurück zum Zitat Tschen SI, Dhawan S, Gurlo T, Bhushan A (2009) Age-dependent decline in β-cell proliferation restricts the capacity of β-cell regeneration in mice. Diabetes 58:1312–1320CrossRefPubMedPubMedCentral Tschen SI, Dhawan S, Gurlo T, Bhushan A (2009) Age-dependent decline in β-cell proliferation restricts the capacity of β-cell regeneration in mice. Diabetes 58:1312–1320CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Shirakawa J, Okuyama T, Yoshida E et al (2014) Effects of the antitumor drug OSI-906, a dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, β-cell functions, and β-cell proliferation in male mice. Endocrinology 155:2102–2111CrossRefPubMed Shirakawa J, Okuyama T, Yoshida E et al (2014) Effects of the antitumor drug OSI-906, a dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, β-cell functions, and β-cell proliferation in male mice. Endocrinology 155:2102–2111CrossRefPubMed
24.
Zurück zum Zitat Rafacho A, Abrantes JL, Ribeiro DL et al (2011) Morphofunctional alterations in endocrine pancreas of short- and long-term dexamethasone-treated rats. Horm Metab Res 43:275–281CrossRefPubMed Rafacho A, Abrantes JL, Ribeiro DL et al (2011) Morphofunctional alterations in endocrine pancreas of short- and long-term dexamethasone-treated rats. Horm Metab Res 43:275–281CrossRefPubMed
25.
Zurück zum Zitat Michael MD, Kulkarni RN, Postic C et al (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87–97CrossRefPubMed Michael MD, Kulkarni RN, Postic C et al (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87–97CrossRefPubMed
26.
Zurück zum Zitat El Ouaamari A, Kawamori D, Dirice E et al (2013) Liver-derived systemic factors drive beta cell hyperplasia in insulin-resistant states. Cell Rep 3:401–410CrossRefPubMedPubMedCentral El Ouaamari A, Kawamori D, Dirice E et al (2013) Liver-derived systemic factors drive beta cell hyperplasia in insulin-resistant states. Cell Rep 3:401–410CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Flier SN, Kulkarni RN, Kahn CR (2001) Evidence for a circulating islet cell growth factor in insulin-resistant states. Proc Natl Acad Sci U S A 98:7475–7480CrossRefPubMedPubMedCentral Flier SN, Kulkarni RN, Kahn CR (2001) Evidence for a circulating islet cell growth factor in insulin-resistant states. Proc Natl Acad Sci U S A 98:7475–7480CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Levitt HE, Cyphert TJ, Pascoe JL et al (2011) Glucose stimulates human beta cell replication in vivo in islets transplanted into NOD-severe combined immunodeficiency (SCID) mice. Diabetologia 54:572–582CrossRefPubMed Levitt HE, Cyphert TJ, Pascoe JL et al (2011) Glucose stimulates human beta cell replication in vivo in islets transplanted into NOD-severe combined immunodeficiency (SCID) mice. Diabetologia 54:572–582CrossRefPubMed
29.
Zurück zum Zitat Porat S, Weinberg-Corem N, Tornovsky-Babaey S et al (2011) Control of pancreatic beta cell regeneration by glucose metabolism. Cell Metab 13:440–449CrossRefPubMed Porat S, Weinberg-Corem N, Tornovsky-Babaey S et al (2011) Control of pancreatic beta cell regeneration by glucose metabolism. Cell Metab 13:440–449CrossRefPubMed
30.
Zurück zum Zitat Vernier S, Chiu A, Schober J et al (2012) β-cell metabolic alterations under chronic nutrient overload in rat and human islets. Islets 4:379–392CrossRefPubMedPubMedCentral Vernier S, Chiu A, Schober J et al (2012) β-cell metabolic alterations under chronic nutrient overload in rat and human islets. Islets 4:379–392CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Stamateris RE, Sharma RB, Kong Y et al (2016) Glucose induces mouse β-cell proliferation via IRS2, MTOR, and cyclin D2 but not the insulin receptor. Diabetes 65:981–995CrossRefPubMed Stamateris RE, Sharma RB, Kong Y et al (2016) Glucose induces mouse β-cell proliferation via IRS2, MTOR, and cyclin D2 but not the insulin receptor. Diabetes 65:981–995CrossRefPubMed
32.
Zurück zum Zitat Assmann A, Ueki K, Winnay JN, Kadowaki T, Kulkarni RN (2009) Glucose effects on β-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2. Mol Cell Biol 29:3219–3228CrossRefPubMedPubMedCentral Assmann A, Ueki K, Winnay JN, Kadowaki T, Kulkarni RN (2009) Glucose effects on β-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2. Mol Cell Biol 29:3219–3228CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–339CrossRefPubMed Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–339CrossRefPubMed
34.
Zurück zum Zitat Okada T, Liew CW, Hu J et al (2007) Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci U S A 104:8977–8982CrossRefPubMedPubMedCentral Okada T, Liew CW, Hu J et al (2007) Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci U S A 104:8977–8982CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Alarcon C, Boland BB, Uchizono Y et al (2016) Pancreatic β-cell adaptive plasticity in obesity increases insulin production but adversely affects secretory function. Diabetes 65:438–450CrossRefPubMed Alarcon C, Boland BB, Uchizono Y et al (2016) Pancreatic β-cell adaptive plasticity in obesity increases insulin production but adversely affects secretory function. Diabetes 65:438–450CrossRefPubMed
36.
Zurück zum Zitat Scaglia L, Smith FE, Bonner-Weir S (1995) Apoptosis contributes to the involution of β cell mass in the post partum rat pancreas. Endocrinology 136:5461–5468PubMed Scaglia L, Smith FE, Bonner-Weir S (1995) Apoptosis contributes to the involution of β cell mass in the post partum rat pancreas. Endocrinology 136:5461–5468PubMed
Metadaten
Titel
Glucose and fatty acids synergistically and reversibly promote beta cell proliferation in rats
verfasst von
Valentine S. Moullé
Kevin Vivot
Caroline Tremblay
Bader Zarrouki
Julien Ghislain
Vincent Poitout
Publikationsdatum
11.01.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 5/2017
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-4197-8

Weitere Artikel der Ausgabe 5/2017

Diabetologia 5/2017 Zur Ausgabe

Up front

Up front

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.